BIM
TCRT icon

BlackRock Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

BlackRock Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.41M Sell
3,000
-15
-0.5% -$13.5K ﹤0.01% 2101
2016
Q3 		$2.55M Buy
3,015
+8
+0.3% +$6.43K ﹤0.01% 1957
2016
Q2 		$2.48M Buy
3,007
+316
+12% +$344K ﹤0.01% 1941
2016
Q1 		$3M Buy
2,691
+126
+5% +$129K ﹤0.01% 1725
2015
Q4 		$3.2M Buy
2,565
+13
+0.5% +$21.5K ﹤0.01% 1725
2015
Q3 		$3.45M Sell
2,552
-36
-1% -$59.4K ﹤0.01% 1644
2015
Q2 		$4.66M Buy
2,588
+823
+47% +$1.28M 0.01% 1555
2015
Q1 		$2.85M Buy
1,765
+206
+13% +$305K ﹤0.01% 1787
2014
Q4 		$1.19M Sell
1,559
-29
-2% -$15.4K ﹤0.01% 2427
2014
Q3 		$629K Buy
1,588
+8
+0.5% +$3.86K ﹤0.01% 2835
2014
Q2 		$955K Buy
1,580
+92
+6% +$51.2K ﹤0.01% 2642
2014
Q1 		$1.02M Buy
1,488
+30
+2% +$20.1K ﹤0.01% 2495
2013
Q4 		$949K Buy
1,458
+185
+15% +$110K ﹤0.01% 2546
2013
Q3 		$753K Buy
1,273
+60
+5% +$27K ﹤0.01% 2648
2013
Q2 		$384K Buy
+1,213
New +$337K ﹤0.01% 2983

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's TCRT Position: Q4 2016 in Review

BlackRock Investment Management reduced its Alaunos Therapeutics (TCRT) stake by 0.5% in Q4 2016, selling an estimated $13.5K and leaving 3,000 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

BlackRock Investment Management first reported a position in TCRT in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.66M in Q2 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • BlackRock Investment Management held 3,000 shares of Alaunos Therapeutics worth $2.41M as of Q4 2016.
  • BlackRock Investment Management sold 15 Alaunos Therapeutics shares in Q4 2016, an estimated $13.5K.
  • Alaunos Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2101 holding.
  • BlackRock Investment Management first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Alaunos Therapeutics position peaked at $4.66M in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.